1800-272-662
Shopping Cart 0
countryflagAU
Login

Curaleaf Holdings Inc

Healthcare US CURLF

2.26USD
0.01(0.44%)

Last update at 2026-03-10T19:58:00Z

Day Range

2.242.31
LowHigh

52 Week Range

2.195.80
LowHigh

Fundamentals

  • Previous Close 2.25
  • Market Cap2538.59M
  • Volume85306
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA115.83M
  • Revenue TTM1402.47M
  • Revenue Per Share TTM1.95
  • Gross Profit TTM 687.59M
  • Diluted EPS TTM-0.64

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -226.42900M 64.80M 22.04M -45.78900M -56.23400M
Minority interest 6.83M 7.40M -0.60100M -5.31600M -5.13100M
Net income -370.09800M -101.73100M -61.73500M -67.24400M -56.46700M
Selling general administrative 475.56M 415.74M 258.15M 137.63M 67.54M
Selling and marketing expenses - - - - -
Gross profit 579.03M 687.59M 390.51M 141.61M 46.29M
Reconciled depreciation 176.47M 132.64M 88.47M 37.21M 8.65M
Ebit - 175.63M 72.44M -4.92900M -20.86300M
Ebitda 43.37M 287.70M 179.51M 16.17M -40.27200M
Depreciation and amortization - - - - -
Non operating income net other - - - - 0.00000M
Operating income -12.37200M 175.63M 63.68M -27.71700M -28.68100M
Other operating expenses - - - - 64.37M
Interest expense 93.33M 90.26M 69.00M 24.75M 7.31M
Tax provision 150.50M 173.93M 83.37M 24.06M 5.64M
Interest income 0.14M 0.63M 6.48M 9.94M 4.80M
Net interest income -93.19300M -89.63300M -62.51800M -14.81500M -2.50400M
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense - 173.93M 87.55M 24.06M 5.64M
Total revenue 1336.34M 1209.66M 626.64M 221.02M 77.06M
Total operating expenses 1348.71M 1034.03M 562.95M 248.74M 105.74M
Cost of revenue 757.31M 522.07M 236.12M 79.41M 30.77M
Total other income expense net -120.86400M -21.20500M 20.88M -3.25700M -25.04900M
Discontinued operations - - - - 0.00000M
Net income from continuing ops -376.93100M -109.13000M -61.32800M -69.84800M -61.87700M
Net income applicable to common shares - -101.73100M -57.16100M -67.24400M -56.46700M
Preferred stock and other adjustments - - - - 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 3397.92M 3262.48M 2386.59M 736.93M 569.84M
Intangible assets 1217.19M 1010.01M 797.40M 185.63M 52.92M
Earning assets - - - - -
Other current assets 32.30M 80.58M 58.50M 19.20M 4.49M
Total liab 1997.10M 1453.99M 1010.38M 333.48M 134.19M
Total stockholder equity 1279.70M 1757.26M 1376.82M 408.76M 440.77M
Deferred long term liab - - - - 0.00000M
Other current liab 41.34M 179.82M 93.40M 46.66M 2.73M
Common stock - 2225.94M 1754.41M 693.70M 657.52M
Capital stock 0.00000M 2225.94M 1754.41M 693.70M 657.52M
Retained earnings -859.55600M -291.39500M -190.07100M -132.91000M -65.66600M
Other liab - 406.19M 209.09M 57.95M 27.46M
Good will 625.13M 605.50M 470.14M 69.33M 47.27M
Other assets - 25.48M 174.90M 68.62M 43.81M
Cash 163.18M 299.33M 73.54M 42.31M 266.62M
Cash and equivalents - - - - -
Total current liabilities 491.08M 315.40M 220.13M 106.26M 24.83M
Current deferred revenue - - - - -
Net debt 459.64M 136.76M 217.96M 62.64M -
Short term debt - - - 17.00M 0.00000M
Short long term debt 51.96M 1.97M 6.50M 17.00M 2.40M
Short long term debt total - - - - -
Other stockholder equity - -172.08100M -177.74400M -146.81900M -146.76100M
Property plant equipment - 664.83M 510.02M 211.26M 66.49M
Total current assets 605.33M 952.26M 417.86M 149.53M 313.46M
Long term investments 2.80M 4.40M 16.26M 51.21M 45.41M
Net tangible assets - 141.75M 134.93M 152.45M 340.11M
Short term investments - - - - 0.00000M
Net receivables 52.16M 66.89M 31.48M 18.34M 9.40M
Long term debt 570.86M 434.12M 285.00M 87.95M 81.90M
Inventory 250.64M 469.80M 244.20M 82.41M 32.47M
Accounts payable 85.26M 26.75M 47.04M 12.74M 3.97M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income - - - - 0.00000M
Additional paid in capital - - - - 0.00000M
Common stock total equity - - - - 0.00000M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity - - - - 0.00000M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - 0.00000M
Non currrent assets other 48.22M 22.05M 35.13M 8.82M 7.44M
Deferred long term asset charges - - - - 0.00000M
Non current assets total 2792.59M 2310.22M 1968.73M 587.39M 256.38M
Capital lease obligations 309.09M 317.56M 286.20M 93.15M 0.00000M
Long term debt total - - - - 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -228.62300M -163.97400M -197.11000M -204.04500M -134.26600M
Change to liabilities - -10.29800M 9.96M 0.53M 1.33M
Total cashflows from investing activities - -163.97400M -197.11000M -204.04500M -134.26600M
Net borrowings - 135.99M 199.02M 16.12M 77.95M
Total cash from financing activities 50.54M 424.80M 224.08M 18.06M 413.01M
Change to operating activities - -3.55200M -8.40200M -0.06100M 7.16M
Net income -370.09800M -101.73100M -57.16100M -67.24400M -56.46700M
Change in cash -131.68300M 225.79M 31.23M -224.30600M 245.64M
Begin period cash flow 299.33M 73.54M 42.31M 266.62M 20.98M
End period cash flow - 299.33M 73.54M 42.31M 266.62M
Total cash from operating activities 46.40M -33.96400M 12.36M -38.32100M -33.10100M
Issuance of capital stock 0.00000M 240.57M 24.55M 0.00000M 403.66M
Depreciation 176.47M 131.76M 78.71M 36.80M 8.56M
Other cashflows from investing activities - 1.47M -4.64600M -41.41000M -16.19800M
Dividends paid - - - - 0.00000M
Change to inventory 31.24M -105.19300M -36.67700M -19.90500M 12.19M
Change to account receivables 7.96M -29.40200M 5.96M -6.94300M -8.14200M
Sale purchase of stock - - -2.50800M -1.27800M -69.31200M
Other cashflows from financing activities - 53.40M -2.50800M -0.39500M -66.64200M
Change to netincome - 23.80M -38.78500M 4.57M 0.27M
Capital expenditures 138.36M 171.96M 126.27M 82.08M 44.90M
Change receivables - - - - 0.00000M
Cash flows other operating - - - - 0.00000M
Exchange rate changes - - - - 0.00000M
Cash and cash equivalents changes - - - - 0.00000M
Change in working capital 110.21M -88.67700M 28.59M -13.99200M 14.44M
Stock based compensation 28.02M 45.63M 29.36M 16.61M -
Other non cash items 11.61M -54.67900M -216.50200M -91.02700M 0.78M
Free cash flow -91.96100M -205.91900M -113.91800M -120.39600M -78.96000M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CURLF
Curaleaf Holdings Inc		 0.01 0.44% 2.26 - 138.89 1.93 2.47 2.48 -111.7404
ZTS
Zoetis Inc		 -1.87 1.53% 120.49 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 0.56 2.23% 25.64 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -2.64 2.02% 128.01 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR		 0.14 0.77% 18.21 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

View All

Profile

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through Domestic Operations and International Operations segments. The company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. In addition, it offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. Further, the company provides hemp-based CBD and cannabigerol products. The company was founded in 2010 and is headquartered in New York, New York.

Curaleaf Holdings Inc

301 Edgewater Place, Wakefield, MA, United States, 01880

Key Executives

Name Title Year Born
Mr. Boris Alexis Jordan Exec. Chairman 1966
Mr. Joseph F. Lusardi Exec. Vice-Chairman 1974
Mr. Joseph Daniel Bayern Exec. Officer & Exec. of New Markets 1963
Mr. Matthew S. Darin Chief Exec. Officer NA
Mr. Edward Kremer Chief Financial Officer 1972
Mr. Joe Holland Exec. VP of Operations NA
Mr. Camilo Russi Lyon Chief Investment Officer NA
Mr. Jakob Feinstein Mang. of Investor Relations NA
Mr. Peter Clateman J.D. Chief Legal Officer 1968
Mr. James S. Shorris Chief Compliance Officer 1962

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.